Key Highlights

● Alphatec plunged in after-hours trading on October 29 after a Revenue warning.

● Its chief executive said third-quarter revenue fell short of expectations.

● Health care was the best-performing S&P 500 sector during the regular session.

● Amazon, Intel, Reddit, Roblox and Twilio also fell after the bell.

Alphatec Holdings (NASDAQ:ATEC) shares plunged in extended trading on Thursday after the spine-surgery technology company's chief executive said third-quarter revenue fell short of expectations.

A late-day blow

Alphatec Holdings plunged in after-hours trading on Thursday, October 29, after its chief executive said third-quarter revenue had fallen short of expectations, according to market data. The stock was among the steepest after-hours decliners in the Russell 2000.

The comments came after the regular session closed, so the move took place in extended trading, where volumes are lighter and prices can shift before the next day's open. Still, the scale of the drop underlined the weight investors place on revenue growth.

What Alphatec does

Alphatec develops and sells technology for spine surgery, including implants, surgical instruments, imaging and navigation systems. The company has been trying to win Market Share from larger competitors by offering an integrated approach that combines devices with information tools surgeons use during procedures.

Growth companies like Alphatec are valued largely on their revenue trajectory. When management signals that sales fell short of expectations, it raises questions about the pace of adoption among surgeons and hospitals, and about the path to profitability.

A health care day turned sour

The after-hours drop contrasted sharply with the regular session for health care stocks. Health care was the best-performing sector in the S&P 500 on Thursday, according to market data.

Eli Lilly (NYSE:LLY) rallied after strong revenue growth and a guidance raise, and Merck (NYSE:MRK) climbed after beating forecasts and lifting its outlook. Among smaller companies, Glaukos (NYSE:GKOS) surged after record sales and Teladoc (NYSE:TDOC) jumped after topping revenue estimates.

Not every health care name participated. MiMedx (NASDAQ:MDXG) slid after missing revenue forecasts, and Iovance Biotherapeutics (NASDAQ:IOVA) plunged on updated lung cancer data. Alphatec joined that list after the bell.

The broader market

Small caps had a strong regular session. The Russell 2000 rose 28.71 points to close at 2,859.22. The S&P 500 slipped 23.59 points to 7,720.39 and the Nasdaq Composite dropped 365.13 points to 26,184.72, weighed down by Alphabet (NASDAQ:GOOGL)'s worst day since its 2004 IPO.

After the bell, the mood darkened. Amazon (NASDAQ:AMZN) and Intel (NASDAQ:INTC) fell sharply in extended trading following their results, and Nasdaq-100 futures dropped, according to market data. Alphatec's slide added to a crowded list of after-hours decliners that also included Reddit (NYSE:RDDT), Roblox (NYSE:RBLX) and Twilio (NYSE:TWLO).

Hospitals, procedures and rates

Spine surgery volumes depend on hospital capacity, surgeon schedules and patient demand. Many procedures are elective, which means they can be postponed when patients face financial pressure or when hospitals are stretched. That can make quarterly revenue lumpier than investors expect.

The economy looks strong. Third-quarter GDP growth accelerated and beat forecasts, and consumer spending held up. But September PCE Inflation ran hot, and the Federal Reserve held rates steady on Wednesday with two officials favouring a hike. For a growth company, higher rates can raise financing costs and weigh on valuations.

What to watch

The first test is Friday's regular session, when investors will see whether the after-hours decline deepens or eases. Full details of Alphatec's results, including the size of the revenue shortfall, surgeon adoption trends and any change to its full-year outlook, will be central.

Analyst estimate and target revisions are likely to follow. Investors will also look for management's explanation of what drove the shortfall, whether it reflected timing, competition or broader procedure trends. The Fed's December 8–9 meeting and Friday's Employment Cost index could shape sentiment toward growth-oriented medical technology stocks.